These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35579012)

  • 21. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades.
    Holmes LE; Kaufman MR; Casella A; Mudavanhu M; Mutunga L; Polzer T; Bassett J; Van Rie A; Schwartz S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25521. PubMed ID: 32603025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082.
    Beauchamp G; Hosek S; Donnell D; Chan KCG; Anderson PL; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    AIDS Behav; 2024 May; 28(5):1512-1521. PubMed ID: 37768427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
    AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa.
    Stranix-Chibanda L; Anderson PL; Kacanek D; Hosek S; Huang S; Nematadzira TG; Taulo F; Korutaro V; Nakabiito C; Masenya M; Lypen K; Brown E; Ibrahim ME; Yager J; Wiesner L; Johnston B; Amico KR; Rooney JF; Chakhtoura N; Spiegel HML; Chi BH;
    Clin Infect Dis; 2021 Oct; 73(7):e1893-e1900. PubMed ID: 33341883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.
    Cabral A; M Baeten J; Ngure K; Velloza J; Odoyo J; E Haberer J; Celum C; Muwonge T; Asiimwe S; Heffron R;
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):154-159. PubMed ID: 29076883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "
    Agot K; Hartmann M; Otticha S; Minnis A; Onyango J; Ochillo M; Roberts ST
    Afr J AIDS Res; 2022 Oct; 21(3):221-230. PubMed ID: 36102052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF; Kamacooko O; Muturi-Kioi V; Chinyenze K; Kuteesa MO; Price MA; Mayanja Y
    BMC Infect Dis; 2022 May; 22(1):467. PubMed ID: 35578163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
    Bonner CP; Browne FA; Carney T; Shangase N; Ndirangu JW; Myers B; Wechsberg WM
    S Afr Med J; 2022 Apr; 112(5):341-346. PubMed ID: 35587247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
    Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
    Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekström AM
    Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
    Medina-Marino A; Bezuidenhout D; Ngwepe P; Bezuidenhout C; Facente SN; Mabandla S; Hosek S; Little F; Celum CL; Bekker LG
    J Int AIDS Soc; 2022 Jul; 25(7):e25968. PubMed ID: 35872602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa.
    O'Rourke S; Hartmann M; Myers L; Lawrence N; Gill K; Morton JF; Celum CL; Bekker LG; van der Straten A
    AIDS Behav; 2021 Jul; 25(7):2154-2165. PubMed ID: 33521908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intimate Partner Violence and Adherence to PrEP and ART Among Ugandan HIV Serodifferent Couples.
    Thomas D; Nakabugo L; Nambi F; Kibuuka J; Muwonge TR; Feutz E; Thomas KK; Simoni JM; Montgomery ET; Ware N; Wyatt MA; Katz IT; Kadama H; Mujugira A; Heffron R;
    J Acquir Immune Defic Syndr; 2024 Apr; 95(4):347-354. PubMed ID: 38133584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intimate Partner Violence Influences Women's Engagement in the Early Stages of the HIV Pre-exposure Prophylaxis (PrEP) Care Continuum: Using Doubly Robust Estimation.
    Willie TC; Keene DE; Stockman JK; Alexander KA; Calabrese SK; Kershaw TS
    AIDS Behav; 2020 Feb; 24(2):560-567. PubMed ID: 30915581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of oral pre-exposure prophylaxis (PrEP) among adolescent girls and young women initiating PrEP for HIV prevention in Kenya.
    de Dieu Tapsoba J; Zangeneh SZ; Appelmans E; Pasalar S; Mori K; Peng L; Tao J; Drain P; Okomo G; Bii S; Mukabi J; Zobrist S; Brady M; Obanda R; Madiang DO; Cover J; Duerr A; Chen YQ; Obong'o C
    AIDS Care; 2021 Jun; 33(6):712-720. PubMed ID: 32951437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of HIV Pre-exposure Prophylaxis use Among Adolescent Girls and Young Women Accessing Routine Sexual and Reproductive Health services in South Africa.
    Martin CE; Cox LA; Nongena P; Butler V; Ncube S; Sawry S; Mullick S
    J Adolesc Health; 2023 Dec; 73(6S):S81-S91. PubMed ID: 37953014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intimate partner and client-perpetrated violence are associated with reduced HIV pre-exposure prophylaxis (PrEP) uptake, depression and generalized anxiety in a cross-sectional study of female sex workers from Nairobi, Kenya.
    Leis M; McDermott M; Koziarz A; Szadkowski L; Kariri A; Beattie TS; Kaul R; Kimani J
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25711. PubMed ID: 34164924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.